Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research Group.
Mattavelli D, Wichmann G, Smussi D, Paderno A, Plana MS, Mesia RN, Compagnoni M, Medda A, Chiocca S, Calza S, Zhan Y, Rognoni C, Tarricone R, Stucchi E, Lorini L, Gurizzan C, Khelik K, Hovig E, Dietz A, Piazza C, Bossi P. Mattavelli D, et al. Among authors: gurizzan c. Front Oncol. 2024 Aug 6;14:1433333. doi: 10.3389/fonc.2024.1433333. eCollection 2024. Front Oncol. 2024. PMID: 39165689 Free PMC article. Review.
Oncological treatment administration at end of life: a retrospective study.
Gurizzan C, Esposito A, Lorini L, Smussi D, Turla A, Baggi A, Laganà M, Zamparini M, Bianchi S, Volta AD, Grisanti S, Giacomelli L, Berruti A, Bossi P. Gurizzan C, et al. Future Oncol. 2024 Feb;20(6):329-334. doi: 10.2217/fon-2023-0092. Epub 2024 Feb 29. Future Oncol. 2024. PMID: 38420932
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR.
Grossi I, Assoni C, Lorini L, Smussi D, Gurizzan C, Grisanti S, Paderno A, Mattavelli D, Piazza C, Pelisenco IA, De Petro G, Salvi A, Bossi P. Grossi I, et al. Among authors: gurizzan c. Oncol Rep. 2024 Mar;51(3):52. doi: 10.3892/or.2024.8711. Epub 2024 Feb 1. Oncol Rep. 2024. PMID: 38299234 Free PMC article.
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
Serafini MS, Cavalieri S, Licitra L, Pistore F, Lenoci D, Canevari S, Airoldi M, Cossu Rocca M, Strojan P, Kuhar CG, Merlano M, Perrone F, Vingiani A, Denaro N, Perri F, Argiris A, Gurizzan C, Ghi MG, Cassano A, Allegrini G, Bossi P, De Cecco L. Serafini MS, et al. Among authors: gurizzan c. J Immunother Cancer. 2024 Jan 30;12(1):e007823. doi: 10.1136/jitc-2023-007823. J Immunother Cancer. 2024. PMID: 38290766 Free PMC article. Clinical Trial.
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma.
Roberti E, Merlano M, Ravanelli M, Alberti A, Esposito A, Gili R, Spinazzé S, Baré C, Jocollé G, Benasso M, Bertolotti F, Vecchio S, Bacigalupo A, Licitra L, Denaro N, Damico M, Lorini L, Gurizzan C, Alfieri S, Bossi P. Roberti E, et al. Among authors: gurizzan c. Oral Oncol. 2023 Oct;145:106540. doi: 10.1016/j.oraloncology.2023.106540. Epub 2023 Aug 9. Oral Oncol. 2023. PMID: 37567147 Clinical Trial.
The present and the future of benzydamine: expert opinion paper.
Bossi P, Gurizzan C, Guntinas-Lichius O, Hainarosie R, Lancini D. Bossi P, et al. Among authors: gurizzan c. Front Oral Health. 2023 Jun 16;4:1191319. doi: 10.3389/froh.2023.1191319. eCollection 2023. Front Oral Health. 2023. PMID: 37405329 Free PMC article.
28 results